Trials / Not Yet Recruiting
Not Yet RecruitingNCT06049472
Patient Perspectives in Mantle Cell Lymphoma Clinical Research
Exploring Patient Engagement Patterns and Participation Trends in Mantle Cell Lymphoma Clinical Trials
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical studies with a distinct emphasis on mantle cell lymphoma play a pivotal role in evaluating the safety and effectiveness of novel treatments for this disease. These trials are instrumental in ascertaining whether new medications surpass conventional therapies, providing substantial evidence to endorse their broad utilization. This particular study stands out as it centers on the firsthand experiences of individuals battling mantle cell lymphoma who are actively engaged in a clinical trial featuring medicinal interventions. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this patient group.
Conditions
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-10-01
- Completion
- 2026-10-01
- First posted
- 2023-09-22
- Last updated
- 2023-09-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06049472. Inclusion in this directory is not an endorsement.